News

Washington DC, Hawaii, Oklahoma, California, Tennessee, West Virginia, Mississippi, Oregon, Washington, Louisiana, Kentucky, and New York all had HBV-related mortality rates higher than the national average.

A faster rate and central location of GCC thinning was associated with lower vision-related quality of life.

Data show the lifetime risk of late AMD ranged from 4.4% for carriers of the nonrisk genotype to 9.4% and 26.8% for heterozygous and homozygous carriers.

Nearly 40% of patients with prurigo nodularis reached clearance or almost-clearance of skin lesions following treatment with nemolizumab.

Weekly 300 mg doses of dupilumab were associated with significant, clinically meaningful improvements by week 24 in patients with eosinophilic esophagitis

Travis Vandergriff, MD, discusses the unique collaboration with ophthalmologists and urologists in the rare skin condition.

The interventional pulmonology specialist discusses new technology and devices available for diagnosing lung cancer.

An analysis of PSOARING 1 and 2 data show the topical therapy is efficacious across a wide spectrum of psoriatic disease and patient demographics.

Women with the highest PTSD symptoms level experienced significantly worse rates of change regarding learning and working memory.

Tenofovir was linked to a decreased incidence rate of HCC compared to entecavir. However, this difference was not considered statistically significant.

According to the results, individuals with SCT who previously had COVID-19 also had various preexisting kidney conditions that were associated with poor outcomes.

A substantial number of individuals (nearly 40%) reached arterial stenosis of at least 50%, according to the findings.

The majority of patients in the phase 2 study met the primary efficacy endpoint of a greater than or equal to a 10% reduction in total stool output over the 6-week efficacy evaluation period.

The increase was highest for Hispanic and non-Hispanic Black Women.

Despite an increased risk of new-onset psoriasis from TNFi treatment, investigators considered the absolute risk to be “modest”, with 241 patient-years of exposure needed for 1 additional event.

Varenicline was efficacious at weeks 12, 24, and 52 of the trial compared with placebo in a smoking cessation program.

During the analysis, investigators became fascinated by how many patients entered the buprenorphine treatment program for OUD having already been taking the drug without a prescription.

Dr. Remo Panaccione speaks on promising long-term data of ustekinumab for Crohn's disease and ulcerative colitis, and how it could function as either a first-line treatment or alternative option for patients who were previously exposed biologic therapies.

An analysis suggests patients on the biologic fared better with adherence and outcomes than those on competitors including adalimumab.

A dive into the manifestation of the rare skin condition, and the impactful role of dermatologists in diagnosing it early.

Dr. Jennifer Green led a panel in discussing new treatments and topics in diabetes care.

Poor initial visual acuity and clock hours of retinitis were significantly associated with RD development, according to new findings.

There was increased PTSD scores found in doctor and nurse responders.

Patients who reported spending 11 or more hours a week tending to their AD had a greater disease burden and frequent changes in mood.

Men and patients aged 65 years and younger had higher incidences of retinal tears.

The restrictive practice of clozapine discontinuation was eliminated in 2015 in the US to allow for greater flexibility for clozapine maintenance.

Incident glaucoma was associated with higher cognitive function scores but steeper rates of cognitive score decline over time.

Dr. Rocha discusses treatment options, overall safety, and patient populations undergoing surgery.